What is it about?
This is a scoping analysis aims to trace the pathway from translational research to technology transfer for further clinical adoption in corneal engineering. We analyzed the current literature about engineering corneal endothelium through a bibliometric and patent analysis. Then, we identified the author's affiliations searching for companies in process of technology transfer for commercialization.
Featured Image
Photo by Jake Weirick on Unsplash
Why is it important?
We identified the gap between the translational research and the technology transfer in this aim and discussed possible causes. We also recognized the willingness of ophthalmologist surgeons to adopt engineered tissues to solve the corneal tissue scarcity for transplantation and the cost-effectiveness of this potential solution.
Perspectives
This scoping analysis shows a first perspective on the gap between the emerging technologies from basic and translational research in corneal engineering. Further analysis including clinical trials being conducted could help to dimension the impact of basic research adoption in the development of novel therapies.
Dr Judith Zavala
Instituto Tecnologico y de Estudios Superiores de Monterrey
Read the Original
This page is a summary of: Corneal tissue engineering: From research to industry, quality of life impact, and Latin American ophthalmologists' perspectives, F1000Research, June 2024, Faculty of 1000, Ltd.,
DOI: 10.12688/f1000research.151005.1.
You can read the full text:
Contributors
The following have contributed to this page
